Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update
by Jessica Moore · The Cerbat GemBasel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 15,664 shares, a decline of 51.9% from the July 15th total of 32,559 shares. Based on an average trading volume of 7,540 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.0% of the company’s stock are sold short.
Basel Medical Group Stock Up 16.5%
BMGL traded up $0.76 during trading on Friday, hitting $5.38. The company had a trading volume of 37,792 shares, compared to its average volume of 6,113. Basel Medical Group has a 1-year low of $4.17 and a 1-year high of $25.80. The company has a current ratio of 1.88, a quick ratio of 1.83 and a debt-to-equity ratio of 0.93. The business has a 50-day moving average of $6.40 and a 200-day moving average of $7.17.
Basel Medical Group (NASDAQ:BMGL – Get Free Report) last announced its quarterly earnings data on Friday, June 26th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $3.21 million for the quarter.
Analysts Set New Price Targets
Separately, Weiss Ratings downgraded Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, August 3rd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.
Read Our Latest Stock Report on Basel Medical Group
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of BMGL. Citadel Advisors LLC acquired a new stake in shares of Basel Medical Group during the 3rd quarter valued at approximately $169,000. Virtu Financial LLC lifted its position in shares of Basel Medical Group by 108.8% in the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after buying an additional 17,608 shares during the last quarter. Finally, Marex Group plc acquired a new position in shares of Basel Medical Group in the 2nd quarter valued at about $25,000.
Basel Medical Group Company Profile
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.